{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-004105","form_type":"8-K","ticker":"ALLR","cik":"0001860657","company_name":"Allarity Therapeutics, Inc.","filed_at":"2023-01-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:47.222872+00:00","generated_at":"2026-06-20T12:40:08.187112+00:00","sec_items":["5.02","5.07","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Allarity Therapeutics: three directors resign, board size reduced to 5; annual meeting adjourned to Feb 3","bullets":["Directors Duncan Moore and Gail Maderis resigned Jan 19, 2023; Soren G. Jensen resigns effective Feb 4, 2023.","Board reduced fixed number of authorized directors from 7 to 5 following the resignations.","2023 annual meeting adjourned on Jan 19 without business; reconvenes Feb 3, 2023 for additional voting time.","Resignations stated as for personal reasons, not due to disagreements with company operations or policies."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-004105","json":"https://secwatch.observer/filing/0001213900-23-004105.json","markdown":"https://secwatch.observer/filing/0001213900-23-004105.md","text":"https://secwatch.observer/filing/0001213900-23-004105.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/ea171929-8k_allarity.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T12:40:08.187112+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5c177db02a","claim":"Gail Maderis resigned as Director at Allarity Therapeutics, Inc..","evidence_excerpt":"On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"eb6e9094b0","claim":"Duncan Moore resigned as Director at Allarity Therapeutics, Inc..","evidence_excerpt":"On January 19, 2023, Mr. Duncan Moore and Ms. Gail Maderis resigned as directors of Allarity Therapeutics, Inc.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"f88085328d","claim":"Soren G. Jensen resigned as Director at Allarity Therapeutics, Inc..","evidence_excerpt":"On January 19, 2023, Mr. Soren G. Jensen gave notice that he will resign as a director, to be effective as of February 4, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390023004105/0001213900-23-004105-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}